⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12069165 | 0.79 | — | — | |
| SCHEMBL21132481 | 0.76 | — | — | |
| SCHEMBL7977394 | 0.76 | — | — | |
| SCHEMBL11070691 | 0.76 | — | — | |
| SCHEMBL19114048 | 0.72 | — | — | |
| SCHEMBL19001422 | 0.72 | — | — | |
| SCHEMBL20006317 | 0.72 | — | — | |
| SCHEMBL22842695 | 0.72 | — | — | |
| SCHEMBL22931430 | 0.67 | — | — | |
| SCHEMBL13920325 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021021761-A1 | UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION | NURIX THERAPEUTICS, INC. (US) | 2021-02-04 | — | — | WO | disclosed |